David C. Pratt Cancer Center — St Louis, Missouri

David C. Pratt Cancer Center is a clinical research site located in St Louis, Missouri, United States 63141.

Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.

David C. Pratt Cancer Center has participated in 5 clinical trials with 4 currently active.

Therapeutic areas: Urinary Bladder Neoplasms, Prostate Cancer, Locally Advanced or Unresectable Metastatic Breast Cancer.

Sponsors: Janssen Research & Development, LLC, Pfizer, Gilead Sciences.

Sponsor Feasibility Report

Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for David C. Pratt Cancer Center?

David C. Pratt Cancer Center has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has David C. Pratt Cancer Center conducted?

David C. Pratt Cancer Center has 5 clinical trials on record, with 4 currently active. Their work covers Urinary Bladder Neoplasms, Prostate Cancer, Locally Advanced or Unresectable Metastatic Breast Cancer.

Is David C. Pratt Cancer Center accredited by Crixeo Health?

Yes — David C. Pratt Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about David C. Pratt Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.